Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: Multi-Centre Based Study Recognition of Atrial Fibrillation With the Corsano CardioWatch 287-2 System

View source ↗

Summary

A multi-center study evaluating the Corsano CardioWatch 287-2 System for recognizing atrial fibrillation and paroxysmal atrial fibrillation; the trial is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corsano CardioWatch 287-2 System

Snippet

Sponsor: Corsano Health B.V. | Conditions: Atrial Fibrillation (AF), Paroxysmal Atrial Fibrillation (PAF) | Status: NOT_YET_RECRUITING